New Mexico Governor Michelle Lujan Grisham has formally requested a state criminal investigation into the Drug Enforcement Administration's handling of fentanyl trafficking, following an Associated Press investigation that exposed federal agents deliberately allowing hundreds of thousands of fentanyl pills to circulate through the state over a two-year period while pursuing larger drug cases.
The governor's request to the state's attorney general raises fundamental questions about federal agency accountability and the wisdom of trading immediate public safety for investigative strategy—a calculation that appears to have cost lives in a state already devastated by opioid addiction.
The Federal Strategy and Its Costs
Between 2023 and 2025, DEA agents repeatedly allowed major fentanyl shipments to continue moving through New Mexico rather than seizing them immediately, according to the AP investigation. Agents pursued this approach while seeking to build cases against higher-ranking traffickers. Current and former DEA agents acknowledged to the AP that the strategy amounted to a gamble with public safety in a state ravaged by the fentanyl epidemic.
The consequences were measurable and severe. While overdose deaths nationwide fell 14% last year, New Mexico experienced a 21% spike in overdose deaths during the same period. Though it remains unclear whether any fatal overdoses can be directly attributed to the DEA strategy, the timing and trajectory raise serious questions about the cost-benefit analysis federal officials employed.
The AP investigation documented an internal report citing a 2023 delivery of 74,000 pills that the DEA surveilled at a mobile home park in Albuquerque—but deliberately did not seize. This represents not a single lapse but a systematic approach to allowing dangerous drugs to reach communities.
Institutional Accountability and Rule of Law
"There are no words to describe how reckless and dangerous these decisions were," Governor Lujan Grisham stated. "Make no mistake: the DEA knew people would die if these pills made it into New Mexico communities, and the agency let it happen anyway."
The governor's statement highlighted a critical institutional failure: federal agents may have violated Justice Department rules specifically designed to safeguard the public from fentanyl, which the White House designated as a "weapon of mass destruction." The White House's own characterization of the drug's lethality makes the DEA's permissive approach particularly difficult to defend on policy grounds.
Lujan Grisham emphasized that state sovereignty and local lives cannot be subordinated to federal investigative priorities: "New Mexican lives are not the federal government's cost of doing business. I plan to hold the federal government accountable for this disaster and will explore every possible avenue of action against the federal government to right these wrongs."
The DEA has not immediately responded to the governor's statement. In previous communications with the AP, the agency claimed that "the investigative decisions at issue were lawful, reasonable under the circumstances and consistent with Department guidance." DEA spokesperson Amanda Wozniak asserted that "public descriptions suggesting that DEA knowingly permitted fentanyl to reach communities are false and fundamentally mischaracterize the facts."
However, Alex Uballez, who served as U.S. attorney in New Mexico from May 2022 until February 2025, offered a different rationale. He told the AP that drugs went unseized at times due to his office's limited resources and his belief that prosecuting larger organizations has a bigger impact than intercepting every suspected drug transaction. This explanation reveals a troubling prioritization: constrained federal resources led officials to effectively conduct an experiment on New Mexico communities.
Growing Scrutiny from Congress and Victims' Advocates
The investigation has prompted congressional attention. DEA whistleblower David Howell, who filed a complaint drawing attention to the unseized fentanyl, met with congressional staffers on Wednesday. Empower Oversight, a whistleblower advocacy group representing Howell, has asked the Senate Judiciary Committee and the Justice Department's Office of Inspector General to investigate the agent's allegations.
Sen. Bernie Moreno, an Ohio Republican, characterized the revelations as "a scandal of the highest order" and stated he plans to determine how many American lives were lost due to the DEA's inaction.
Victims' advocates have also condemned the federal approach. Michael Glownia, who lost his daughter to fentanyl in the third year and founded a nonprofit organization to support families suffering similar losses, expressed the human cost of the policy: "Knowing the Justice Department had guidelines to seize the opioids whenever practical—and the fact these were ignored—is truly heartbreaking."
The contradiction between the DEA's public messaging and its operational decisions has not escaped notice. The agency's prominent "One Pill Can Kill" campaign warns that as little as a few milligrams of fentanyl can cause a fatal overdose—a message that directly contradicts the agency's willingness to allow hundreds of thousands of pills to reach the streets in pursuit of larger cases.
Why This Matters:
This case represents a fundamental failure of federal accountability and institutional restraint. When federal agencies operate with insufficient oversight, they can impose costs on state and local communities without bearing the consequences of their decisions. The DEA's approach—allowing dangerous drugs to circulate to build cases against larger traffickers—exemplifies the problem of unaccountable bureaucratic discretion. The fact that New Mexico experienced a 21% spike in overdose deaths while the national average fell suggests the federal strategy may have directly harmed the communities it was supposed to protect. Governor Lujan Grisham's call for state-level investigation reasserts an important principle: federal agencies must answer to elected officials and the rule of law, particularly when their decisions affect public safety. The case also raises questions about resource allocation and federal priorities—whether building cases against higher-ranking traffickers justifies allowing fentanyl pills to reach communities. From a governance perspective, this incident demonstrates why limiting federal power and maintaining state authority over public safety matters in practice, not merely in theory.